For patients with lung cancer, biomarker testing may be an option.

We’re working to bring the hope of advanced medicine to more patients.

Researchers focus on reversing the scarring that’s common to liver diseases.

Our Global Head of Precision Medicine in Oncology discusses her day-to-day work at Novartis.

Myriam Mendila describes how Novartis continued supporting cancer patients and healthcare professionals during the pandemic.

Advanced Accelerator Applications is working on marrying targeted drug design with nuclear medicine technology to develop drugs that can recognize and treat diseases.